false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Glomeru ...
Novel Treatment Options for C3 Glomerulopathy and ...
Novel Treatment Options for C3 Glomerulopathy and Membranoproliferative Glomerulonephritis
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Joshua Thurman reviews emerging treatments for C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (MPGN). C3G is diagnosed by kidney biopsy showing C3 deposition greatly exceeding immunoglobulin, although post-infectious disease must sometimes be excluded. Complement dysregulation drives injury; causes can include autoantibodies, genetic susceptibility, environmental triggers, and monoclonal gammopathy.<br /><br />C3G is rare but often progresses to kidney failure and frequently recurs after transplantation. Two complement inhibitors have been approved: oral iptacopan, which targets the alternative pathway, and subcutaneous pegcetacoplan, which blocks C3. Clinical trials showed reduced proteinuria, supporting complement blockade as a primary treatment option. Pegcetacoplan also has evidence in immune-complex MPGN and transplant recurrence. For patients with a monoclonal gammopathy, clone-directed therapy may be preferable, based on retrospective evidence of improved kidney outcomes. Mycophenolate may be considered when complement inhibitors are unavailable, but evidence is less robust.<br /><br />Complement inhibition carries infection risks, making vaccination essential. Important questions remain about treatment duration, remission criteria, pediatric care, pregnancy, antibiotic prophylaxis, and transplant prevention. Thurman emphasizes screening adults with C3G for monoclonal gammopathy and tailoring treatment to biopsy findings and underlying causes.
Asset Caption
Joshua M. Thurman, MD, FASN
Meta Tag
Speaker
Joshua M. Thurman
Keywords
C3 glomerulopathy
immune-complex membranoproliferative glomerulonephritis
complement dysregulation
iptacopan
pegcetacoplan
monoclonal gammopathy
kidney transplantation
×
Please select your language
1
English